CS logo
small CS logo
Hospital del Mar; Servicio de Hematologia

Barcelona, Spain
General hospital in Barcelona
Passeig Marítim de la Barceloneta, 25, 29, 08003 Barcelona

About Hospital del Mar; Servicio de Hematologia


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Hospital del Mar; Servicio de Hematologia


During the past decade, Hospital del Mar; Servicio de Hematologia conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital del Mar; Servicio de Hematologia" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator and "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at Hospital del Mar; Servicio de Hematologia


According to Clinical.Site data, the most researched conditions in "Hospital del Mar; Servicio de Hematologia" are "Non-Hodgkin's Lymphoma" (2 trials), "Advanced Follicular Lymphoma" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials) and "Lymphocytic Leukemia, Chronic" (1 trials). Many other conditions were trialed in "Hospital del Mar; Servicio de Hematologia" in a lesser frequency.

Clinical Trials Intervention Types at Hospital del Mar; Servicio de Hematologia


Most popular intervention types in "Hospital del Mar; Servicio de Hematologia" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Obinutuzumab" (4 trials), "Cyclophosphamide" (3 trials), "Doxorubicin" (3 trials), "Vincristine" (3 trials) and "Bendamustine" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Hospital del Mar; Servicio de Hematologia


The vast majority of trials in "Hospital del Mar; Servicio de Hematologia" are 5 trials for "All" genders.

Clinical Trials Status at Hospital del Mar; Servicio de Hematologia


Currently, there are NaN active trials in "Hospital del Mar; Servicio de Hematologia". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital del Mar; Servicio de Hematologia, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital del Mar; Servicio de Hematologia, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".